Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 13,015 | 10,624 | 12,752 | 9,228 | 7,214 |
| Operating Income | -13,015 | -10,624 | -12,752 | -9,228 | -7,214 |
| Other Income | -21 | 17 | 17 | 12 | 2 |
| Pre-tax Income | -13,036 | -10,607 | -12,735 | -9,216 | -7,212 |
| Net Income Continuous | -13,036 | -10,607 | -12,735 | -9,216 | -7,212 |
| Net Income | $-13,036 | $-10,607 | $-12,735 | $-9,216 | $-7,212 |
| EPS Basic Total Ops | -5.30 | 22.40 | -5.20 | -4.30 | -34.80 |
| EPS Basic Continuous Ops | -5.33 | 22.44 | -5.22 | -4.31 | -34.82 |
| EPS Diluted Total Ops | -5.30 | 22.40 | -5.20 | -4.30 | -34.80 |
| EPS Diluted Continuous Ops | -5.33 | 22.44 | -5.22 | -4.31 | -34.82 |
| EBITDA(a) | $-12,995 | $-10,518 | $-12,659 | $-9,185 | $-7,204 |